Clinical Trial Update: Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating nasal microbiome therapy (NMT) to reestablish diversity in the infant nasal microbiome after intranasal mupirocin treatment; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Colonization
• Staphylococcus Aureus Infection

Drugs mentioned

• Nasal Microbiome Therapy (NMT) (nasal microbiome therapy)

Snippet

Sponsor: Johns Hopkins University | Conditions: Staphylococcal Aureus Infection, Microbial Colonization | Phase 1 | Status: RECRUITING